blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Behind the scenes at Sano: Navigating the patient journey

Advocating for patients is one of the core pillars of Sano’s mission. Our approach to clinical trials is patient-centered and entails deep and meaningful engage...
Continue reading

Overcoming rare disease trial hurdles: Q&A with Sano's Head of Clinical Engagement 

Rare disease trials are among the most challenging to design and execute. Patient populations are small and hard to reach, and personal and disease-related burd...
Continue reading

Building trust in clinical trial patient matching: Takeaways from DPHARM 2025

At this year’s DPHARM conference, Sano’s VP of Commercial, Ben Jackson, joined a panel on clinical trial patient matching moderated by a clinical expert from No...
Continue reading

Q2 2025 product update: New features for seamless trial execution

At Sano Genetics, our mission is to make clinical research in precision medicine faster, more inclusive, and more efficient. In our Q2 2025 product webinar, we ...
Continue reading

When systems align: Boosting site engagement through smart integration

Site disengagement can be a major barrier to successful and timely trial execution. A significant contributor to disengagement is overloading sites with redunda...
Continue reading

Introducing the Sano Referral Manager: Bridging the gap from referral to randomization

Clinical trial recruitment is notoriously difficult, and nowhere is this more acute than at the referral stage. When a participant who looks potentially eligibl...
Continue reading

Modernizing rare disease trials with patient-centered innovation

While there have been significant strides in the development of drugs for rare diseases over the past few decades, only 5% of rare diseases have FDA-approved tr...
Continue reading

Beyond recruitment: Building lasting relationships with trial participants

As clinical trials become more complex and patient populations more diverse, the traditional focus on recruitment alone is no longer enough. Building long-term ...
Continue reading

Podcast recap: Sharon Terry on patient-led research, biobanking, and the future of rare disease advocacy

In the latest episode of The Genetics Podcast, host Patrick Short sat down with Sharon Terry, the CEO of Genetic Alliance, to discuss her extraordinary journey ...
Continue reading